[Doxepin, a new antidepressant: comparison of effects with amitriptyline].
D000208:Acute Disease; D000275:Adjustment Disorders / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003989:Dibenzoxazepines / Q000627:therapeutic use*; D003990:Dibenzoxepins / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D013268:Stimulation, Chemical
D003989:Dibenzoxazepines; D003990:Dibenzoxepins; D000639:Amitriptyline; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase
Dexepin, ein neues Antidepressivum: Wirkungsvergleich mit Amitriptylin.